Literature DB >> 9647548

Treatment-independent pregnancy rate in patients with severe reproductive disorders.

J L Evers1, H W de Haas, J A Land, J C Dumoulin, G A Dunselman.   

Abstract

A long waiting list for in-vitro fertilization (IVF) offers the possibility to study treatment-independent pregnancy rates in patients with severe reproductive disorders. We performed a retrospective cohort study with a nested case-control design in which the cases achieved a spontaneous pregnancy while on the waiting list for IVF, or for IVF with intracytoplasmic sperm injection (ICSI), and the controls did not become pregnant while on the waiting list. Spontaneous pregnancies occurred in 76 of 1391 patients on the waiting list. Significant differences between pregnant and non-pregnant patients were found for duration of subfertility (couples on the IVF waiting list), and for progressive sperm motility and basal 17beta-oestradiol (couples on the ICSI waiting list). The 12 months cumulative pregnancy rate for patients on the waiting list was 2.4% (95% CI 1.2-3.9%) for tubal subfertility patients, 5.9 % (3.7-8.7%) for longstanding unexplained subfertility patients, and 6.6% (4.5-9.3%) for male subfertility patients. Of the 76 control patients, 21% of tubal subfertility patients, 18% of unexplained subfertility patients, and 17% of male subfertility patients achieved a pregnancy in their first IVF or ICSI treatment cycle. We confirm that the treatment-independent pregnancy rate in patients with severe reproductive disorders is low. More than 75% of the spontaneous pregnancies in the tubal subfertility and unexplained subfertility couples occurred during their first three months on the waiting list, whereas spontaneous pregnancy rate in male subfertility couples showed a more gradual but persisting increase. We conclude that one cycle of IVF or ICSI is superior to 12 months of expectant management in patients with severely impaired fertility due to tubal, unexplained or male factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647548     DOI: 10.1093/humrep/13.5.1206

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Likelihood of natural conception following treatment by IVF.

Authors:  D J Cahill; J Meadowcroft; V A Akande; E Corrigan
Journal:  J Assist Reprod Genet       Date:  2005-12       Impact factor: 3.412

Review 2.  Misconceptions about falling sperm counts and fertility in Europe.

Authors:  Egbert R te Velde; Jens Peter Bonde
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

3.  Special characteristics, reproductive, and clinical profile of women with unexplained infertility versus other causes of infertility: a comparative study.

Authors:  Charalampos Siristatidis; Abraham Pouliakis; Theodoros N Sergentanis
Journal:  J Assist Reprod Genet       Date:  2020-06-05       Impact factor: 3.412

4.  The effect of coenzyme Q₁₀ supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia: an open-label prospective study.

Authors:  Mohammad Reza Safarinejad
Journal:  Int Urol Nephrol       Date:  2011-11-13       Impact factor: 2.370

5.  Fertilization of IVF/ICSI using sibling oocytes from couples with subfertile male or unexplained infertility.

Authors:  Zhiling Li; Hong Lin; Wanfen Xiao; Yulian Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 6.  Surgery for tubal infertility.

Authors:  Su Jen Chua; Valentine A Akande; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2017-01-23

7.  Time to pregnancy: a computational method for using the duration of non-conception for predicting conception.

Authors:  Peter D Sozou; Geraldine M Hartshorne
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

8.  Effect of the anterior uterocervical angle in unexplained infertility: a prospective cohort study.

Authors:  Ilknur Col Madendag; Mefkure Eraslan Sahin; Yusuf Madendag; Erdem Sahin; Mustafa Bertan Demir; Fatma Ozdemir; Gokhan Acmaz; Iptisam Ipek Muderris
Journal:  J Int Med Res       Date:  2019-12-25       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.